These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11563868)

  • 1. Immunology of human papillomavirus infection in lower genital tract neoplasia.
    Man S; Fiander A
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):701-14. PubMed ID: 11563868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human papillomavirus vaccines in cervical neoplasia.
    Stern PL; Faulkner R; Veranes EC; Davidson EJ
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL; Passmore JA; Rybicki EP
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viruses and cervical cancers].
    Mathevet P
    Rev Prat; 2001 Sep; 51(13):1413-6. PubMed ID: 11601069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The biology of papillomavirus infections. III. Immune response].
    Greslin I; Mougin C; Seilles E
    Ann Biol Clin (Paris); 1998; 56(3):267-76. PubMed ID: 9754259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
    Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
    Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
    Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
    Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.
    Davidson EJ; Boswell CM; Sehr P; Pawlita M; Tomlinson AE; McVey RJ; Dobson J; Roberts JS; Hickling J; Kitchener HC; Stern PL
    Cancer Res; 2003 Sep; 63(18):6032-41. PubMed ID: 14522932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
    Berumen J; Villegas N
    Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous regression of grade 3 vulvar intraepithelial neoplasia associated with human papillomavirus-16-specific CD4(+) and CD8(+) T-cell responses.
    Bourgault Villada I; Moyal Barracco M; Ziol M; Chaboissier A; Barget N; Berville S; Paniel B; Jullian E; Clerici T; Maillère B; Guillet JG
    Cancer Res; 2004 Dec; 64(23):8761-6. PubMed ID: 15574788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.
    Revaz V; Zurbriggen R; Moser C; Schiller JT; Ponci F; Bobst M; Nardelli-Haefliger D
    Antiviral Res; 2007 Oct; 76(1):75-85. PubMed ID: 17617476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the immune system in anogenital human papillomavirus.
    Frazer IH
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes.
    Nicholls PK; Moore PF; Anderson DM; Moore RA; Parry NR; Gough GW; Stanley MA
    Virology; 2001 Apr; 283(1):31-9. PubMed ID: 11312659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do "high-risk" human papillomavirus (HPV) types lead to cancer by evading the immune system?
    Tendler A; Ho GY; Kadish AS
    Gynecol Oncol; 1999 Apr; 73(1):169-70. PubMed ID: 10094902
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune cellular response to HPV: current concepts.
    Gonçalves MA; Donadi EA
    Braz J Infect Dis; 2004 Feb; 8(1):1-9. PubMed ID: 15137933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccines.
    Stanley MA
    Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.